市場調査レポート

血液スクリーニング・血液型決定の世界市場

Blood Screening and Typing Markets

発行 Kalorama Information 商品コード 352106
出版日 ページ情報 英文 117 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
血液スクリーニング・血液型決定の世界市場 Blood Screening and Typing Markets
出版日: 2016年01月20日 ページ情報: 英文 117 Pages
概要

ウイルスや細菌、原生動物など、血液には様々な感染物質が存在しています。血液型決定と血液検査は、輸血する血液がレシピエントにとって安全であることを確実にするための基礎となります

当レポートでは、世界の血液スクリーニング・血液型決定市場について調査し、市場の動向と2020年までの成長予測、技術革新動向、および主要参入企業のプロファイルをまとめています。

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • 血液型決定におけるミスの低減
    • ドナースクリーニングの改良
    • ウイルススクリーニングの改良
    • 再献血率の向上
    • ウイルス不活化プロセスの促進
    • 自発的献血の増加
    • 細菌感染の予防
    • バイオビジランス
    • その他の安全警告
  • 血液型決定
    • 血液型決定の方法
    • 血液検査
    • 核酸増幅検査
    • CBER認可NATスクリーニング検査
    • ポリメラーゼ連鎖反応 (PCR) 増幅
    • CBER認可PCRスクリーニング検査
    • 免疫測定
    • 酵素結合免疫吸着検査法
    • コストおよび他の障壁
    • 血液保存
  • 輸血
  • 血液病原菌スクリーニング

第3章 市場分析

  • 血液バンキング
  • 血液型決定
  • 免疫測定
  • 核酸検査
  • 血液検査における市場シェア

第4章 企業プロファイル

  • Abbott Diagnostics
  • AXO Science
  • Beckman Coulter
  • bioMerieux Inc
  • Cerus Corporation
  • DiaSorin S.p.A
  • Grifols
  • Blood Transfusion Novartis Business
  • International Programs
  • Haemonetics Corporation
  • Hologic, Inc.
  • Product News
  • The Gen-Probe Business
  • Panther System
  • Blood Bank
  • Quest Contract
  • Immucor, Inc.
  • Immunetics Inc.
  • Ortho Clinical Diagnostics
  • Quotient Limited
  • Roche Diagnostics
  • Terumo BCT
  • Verax Biomedical Inc.

図表

目次
Product Code: KLI5841881

A variety of infectious agents can be present in blood, including viruses, bacteria, protozoans, Chagas disease, Lyme Disease, and prions. Blood typing and testing represents the cornerstone of ensuring that transfused blood is safe for the recipient and free of disease. Blood Screening and Typing Markets examines the infectious disease blood typing and the infectious disease blood screening markets, including ABO grouping, molecular and nucleic-acid testing (NAT) blood screening, and immunodiagnostic blood screening.

The report provides complete market analysis of the blood screening and typing markets, including:

  • Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
  • Selected Blood Typing Innovations
  • Blood Typing by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Infectious Disease Blood Typing Market Share by Company
  • Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Selected New Blood Screening Immunoassays
  • NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Selected New Blood Screen NAT Tests and Systems
  • Infectious Disease Blood Screening Test Market Share by Company

The report provides a comprehensive overview of the blood screening and typing markets, discussing:

  • Risk of Contamination
  • Viral Inactivation by Procedure
  • Basic Blood Types
  • Blood Transfusion Compatibility
  • PCR-Based Screening Tests Licensed by CBER
  • Comparison of Direct and Indirect ELISA Tests
  • Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
  • Blood Component Usage
  • Pathogens Commonly Tested in Donated Blood Units
  • Selected Pathogen Screening Innovations

Blood Screening and Typing Markets profiles a selection of companies that specialize in blood banking and that contribute molecular test innovation to this segment. Companies discussed include:

  • Abbott Diagnostics
  • AXO Science
  • Beckman Coulter
  • bioMérieux Inc.
  • Cerus Corporation
  • DiaSorin S.p.A.
  • Grifols
  • Haemonetics Corporation
  • Hologic, Inc.
  • Immucor, Inc.
  • Immunetics Inc.
  • Ortho Clinical Diagnostics
  • Quotient Limited
  • Roche Diagnostics
  • Terumo BCT
  • Verax Biomedical Inc.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Blood Screening
  • Blood Typing
  • The Market for Blood Testing and Typing

TWO: INTRODUCTION

  • Reducing Blood Typing Errors
  • Improving Donor Screening
  • Improving Viral Screening
  • Increasing Repeat Donation Rates
  • Enhancing Viral Inactivation Processes
  • Increasing Voluntary Donation
  • Preventing Bacterial Infections
  • Biovigilance
  • Other Safety Precautions
  • Blood Typing
  • Methods of Blood Typing
  • Blood Testing
  • Nucleic Acid Amplification Testing (NAT)
  • CBER Licensed NAT Screening Tests
  • Polymerase Chain Reaction (PCR) Amplification
  • CBER Licensed PCR Screening Tests
  • Immunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Costs and Other Barriers
  • Blood Storage
  • Blood Transfusions
  • Blood Pathogen Screening

THREE: MARKET ANALYSIS

  • Blood Banking Gets a Shakeup
  • Blood Typing
  • Blood Grouping and Typing
  • Immunoassays
  • Nucleic Acid Testing (NAT)
  • Market Share in Blood Testing

FOUR: COMPANY PROFILES

  • Abbott Diagnostics
  • AXO Science
  • Beckman Coulter
  • bioMérieux Inc
  • Cerus Corporation
  • DiaSorin S.p.A
  • Grifols
  • Blood Transfusion Novartis Business
  • International Programs
  • Haemonetics Corporation
  • Hologic, Inc.
  • Product News
  • The Gen-Probe Business
  • Panther System
  • Blood Bank
  • Quest Contract
  • Immucor, Inc.
  • Immunetics Inc.
  • Ortho Clinical Diagnostics
  • Quotient Limited
  • Roche Diagnostics
  • Terumo BCT
  • Verax Biomedical Inc.

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

  • Figure 1-1: The Market for Blood Testing and Typing, 2015 and 2020

TWO: INTRODUCTION

  • Table 2-1: Risk of Contamination
  • Table 2-2: Viral Inactivation by Procedure
  • Table 2-3: Basic Blood Types
  • Table 2-4: Blood Transfusion Compatibility
  • Table 2-5: PCR-Based Screening Tests Licensed by CBER
  • Table 2-6: Comparison of Direct and Indirect ELISA Tests
  • Table 2-7: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
  • Table 2-8: Blood Component Usage
  • Table 2-9: Pathogens Commonly Tested in Donated Blood Units
  • Table 2-10: Selected Pathogen Screening Innovations

THREE: MARKET ANALYSIS

  • Table 3-1: Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
  • Figure 3-1: Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
  • Table 3-2: Selected Blood Typing Innovations
  • Figure 3-2: Blood Typing by Country, 2015 (United States, Italy, Germany, UK,
  • France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Table 3-3: Infectious Disease Blood Typing Market Share by Company
  • Figure 3-3: Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Table 3-4: Selected New Blood Screening Immunoassays
  • Figure 3-4: NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
  • Table 3-5: Selected New Blood Screen NAT Tests and Systems
  • Table 3-6: Infectious Disease Blood Screening Test Market Share by Company
Back to Top